Over the past decades, many biomarkers, including neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule 1 (KIM-1), and interleukin 18 (IL18), have been studied for the early diagnosis of AKI, but their diagnostic sensitivity is relatively low36–38. The gene discussed is IL18; the disease is acute kidney injury.